安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Assertio Holdings
Assertio Holdings, Inc to Report First Quarter 2025 Financial Results on May 12, 2025 Read More
- Assertio Holdings, Inc. - Investor Relations
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients and has a robust portfolio of branded prescription products in neurology, oncology, hospital and pain and inflammation
- Assertio Holdings » Overview
Welcome to Assertio We are a leading commercial pharmaceutical company bringing differentiated products to patients We have a robust portfolio of branded prescription neurology, inflammation, pain and oncology medications
- Assertio Holdings » Products
To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 800-518-1084 or medinfo@assertiotx com
- Assertio Holdings » Management
Dr Franklin has served as Senior Vice President, Medical, of Assertio since March 2023 He oversees Assertio’s medical and clinical scientific leadership for development programs, product assessments and life cycle management
- Assertio Holdings, Inc. - News
At Assertio Holdings, Inc we promise to treat your data with respect and will not share your information with any third party You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below If you experience any issues with this process, please contact us for further assistance
- Assertio Holdings » Board of Directors
Mr Kirk has served as a director of Assertio since April 2024 Mr Kirk is a senior corporate business development executive with more than 20 years of pharmaceutical experience in the areas of branded biopharmaceutical, medical device and generic products
- Assertio Holdings » Overview
Embrace a New Career at Assertio Holdings Welcome to Assertio, where our goal as an employer is simple: To make working with us the best career experience of your life How?
|
|
|